These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 32668011)

  • 21. A quantitative approach to predicting lung deposition profiles of pharmaceutical powder aerosols.
    Yaqoubi S; Chan HK; Nokhodchi A; Dastmalchi S; Alizadeh AA; Barzegar-Jalali M; Adibkia K; Hamishehkar H
    Int J Pharm; 2021 Jun; 602():120568. PubMed ID: 33812969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the two tachykinin antagonists, SR 48968 and SR 140333, on cough induced by citric acid in the unanaesthetized guinea pig.
    Girard V; Naline E; Vilain P; Emonds-Alt X; Advenier C
    Eur Respir J; 1995 Jul; 8(7):1110-4. PubMed ID: 7589394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Respiratory Tract Disease on Particle Deposition.
    Bennett WD
    J Aerosol Med Pulm Drug Deliv; 2021 Sep; 34(5):269-273. PubMed ID: 34435873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical relevance of dry powder inhaler performance for drug delivery.
    Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
    Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Afferent neural pathways in cough and reflex bronchoconstriction.
    Karlsson JA; Sant'Ambrogio G; Widdicombe J
    J Appl Physiol (1985); 1988 Sep; 65(3):1007-23. PubMed ID: 3053580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acid-sensing by airway afferent nerves.
    Lee LY; Gu Q; Xu F; Hong JL
    Pulm Pharmacol Ther; 2013 Oct; 26(5):491-7. PubMed ID: 23524016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance.
    Bosquillon C; Lombry C; Préat V; Vanbever R
    J Control Release; 2001 Feb; 70(3):329-39. PubMed ID: 11182203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bronchoconstriction-triggered cough in conscious guinea pigs.
    Ohkura N; Fujimura M; Hara J; Ohsawa M; Kamei J; Nakao S
    Exp Lung Res; 2009 May; 35(4):296-306. PubMed ID: 19415547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of particle properties in pharmaceutical powder inhalation formulations.
    Chew NY; Chan HK
    J Aerosol Med; 2002; 15(3):325-30. PubMed ID: 12396421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Pressurized Metered Dose Inhaler Spray Characteristics and Particle Size Distribution on Drug Delivery Efficiency.
    Yousefi M; Inthavong K; Tu J
    J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):359-372. PubMed ID: 28463041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient Nose-to-Lung (N2L) Aerosol Delivery with a Dry Powder Inhaler.
    Longest PW; Golshahi L; Behara SR; Tian G; Farkas DR; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):189-201. PubMed ID: 25192072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Numerical simulation of the effect of inhalation parameters, gender, age and disease severity on the lung deposition of dry powder aerosol drugs emitted by Turbuhaler®, Breezhaler® and Genuair® in COPD patients.
    Horváth A; Farkas Á; Szipőcs A; Tomisa G; Szalai Z; Gálffy G
    Eur J Pharm Sci; 2020 Nov; 154():105508. PubMed ID: 32836137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CFD Guided Optimization of Nose-to-Lung Aerosol Delivery in Adults: Effects of Inhalation Waveforms and Synchronized Aerosol Delivery.
    Dutta R; Spence B; Wei X; Dhapare S; Hindle M; Longest PW
    Pharm Res; 2020 Sep; 37(10):199. PubMed ID: 32968848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cough and bronchoconstriction mediated by capsaicin-sensitive sensory neurons in the guinea-pig.
    Forsberg K; Karlsson JA; Theodorsson E; Lundberg JM; Persson CG
    Pulm Pharmacol; 1988; 1(1):33-9. PubMed ID: 2980286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computational Models of Inhalation Therapy in Early Childhood: Therapeutic Aerosols in the Developing Acinus.
    Katan JT; Hofemeier P; Sznitman J
    J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):288-98. PubMed ID: 26907858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The size and behavior of the human upper airway during inhalation of aerosols.
    Nikander K; von Hollen D; Larhrib H
    Expert Opin Drug Deliv; 2017 May; 14(5):621-630. PubMed ID: 27547842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Devices for Improved Delivery of Nebulized Pharmaceutical Aerosols to the Lungs.
    Longest W; Spence B; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2019 Oct; 32(5):317-339. PubMed ID: 31287369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic optimisation of asthma treatment.
    Taburet AM; Schmit B
    Clin Pharmacokinet; 1994 May; 26(5):396-418. PubMed ID: 7914480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing lung regions of interest in gamma scintigraphy for assessing inhaled therapeutic aerosol deposition.
    Biddiscombe MF; Meah SN; Underwood SR; Usmani OS
    J Aerosol Med Pulm Drug Deliv; 2011 Jun; 24(3):165-73. PubMed ID: 21453048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection.
    Empey DW; Laitinen LA; Jacobs L; Gold WM; Nadel JA
    Am Rev Respir Dis; 1976 Feb; 113(2):131-9. PubMed ID: 1247226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.